To compare attitudes and practices related to clinicians'use of depot medroxyprogesterone acetate [Depo-Provera (DMPA) ] and levonorgestrel implants in adolescents in three northern European countries and the United States.
Between the fall of 1993 and the winter of 1995, surveys eliciting clinician attitudes and practices with the two contraceptive methods were collected from practitioners who provide contraceptive care to teens in Sweden (n=282), The Netherlands (n=197), Great Britain (n=108), and the United States (n=548).
Clinicians in Great Britain and the United States reported prescribing of DMPA, selected DMPA in their top three choices for contraception in teens, and had patients ask about DMPA more frequently than clinicians in Sweden or The Netherlands (p<0.0001).
U.S. clinicians were more likely to report prescribing of the implants, list them as a top choice, and have patients ask for it more frequently than were providers in the other three countries (p<0.0001).
Noncompliance with previous contraceptives was the most common indication for use of either method in this age group. « Worst fears » with DMPA use included infertility, particularly among Swedish clinicians (p<0.0001), as was pregnancy and loss to follow-up, particularly among British clinicians (p<0.0001).
Condom nonuse was a concern associated with both methods. (...)
Mots-clés Pascal : Prévention, Gestation, Contraception, Lévonorgestrel, Médroxyprogestérone, Contraceptif, Personnel sanitaire, Attitude, Etude comparative, Etats Unis, Amérique du Nord, Amérique, Europe, Forme libération contrôlée, Adolescent, Homme, Femelle
Mots-clés Pascal anglais : Prevention, Pregnancy, Contraception, Levonorgestrel, Medroxyprogesterone, Contraceptive, Health staff, Attitude, Comparative study, United States, North America, America, Europe, Controlled release form, Adolescent, Human, Female
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0448527
Code Inist : 002B20A01. Création : 25/01/1999.